UBS Downgrades Afya to Neutral, Lowers Price Target to $16
Benzinga Newsdesk 9 months ago
NewsDowngradesPrice TargetAnalyst Ratings
UBS analyst Andre Salles downgrades Afya (NASDAQ:AFYA) from Buy to Neutral and lowers the price target from $18 to $16.
UBS analyst Andre Salles downgrades Afya (NASDAQ:AFYA) from Buy to Neutral and lowers the price target from $18 to $16.